Research
The University of Pittsburgh Department of Medicine is a formidable leader in cutting-edge research. Our basic scientists, clinical researchers, and clinicians work daily to make research discoveries that will positively impact the world’s healthcare.
Education and Training
Faculty and staff are actively engaged in training the next generation of physicians and scientists at all stages of medical education.
Clinical
Providing state-of-the-art health care that is compassionate, comprehensive, and easily accessible to patients.
Dr. Jason Rose Appointed as Associate Vice Chair for Innovation and Commercialization
In this newly created position, Dr. Rose will work to foster innovation and commercialization opportunities for investigators throughout the Department of Medicine in a collaboration with UPMC Enterprises and the University of Pittsburgh.
Dr. Kathleen McTigue named as Inaugural Vice Chair for Real World Evidence
In this role, she will support the use of real-world evidence in health research by facilitating access to data and nurturing partnerships with industry partnerships to support research undertaken by DOM clinicians and researchers.
Sarah Gaffen, PhD, elected fellow of the American Association for the Advancement of Science
Professor of Medicine in the Division of Rheumatology and Clinical Immunology, Dr. Sarah Gaffen is an international expert on IL-17 and its role in autoimmune diseases. She is one of only four Pitt faculty to be elected to the AAAS this year.
VMI Director Stephen Chan, MD, PhD receives a $6.2 million grant from the Wood Next Fund
The grant will allow Dr. Chan and Co-PI Dr. Colleen McClung to study the genetic underpinnings of sleep dysfunction.
Research from the Cancer Immunotherapeutics Center led by Dr. Jason Luke leads to FDA approval of melanoma treatment
Based on results from the KEYNOTE-716 trial led by Dr. Jason Luke, pembrolizumab resulted in a marked improvement in recurrence-free survival (RFS) and reduced disease recurrence or death by 35%, leading to its approval for treatment of patients 12 years and older...
NIH U54 leads to creation of TriState SenNet Tissue Mapping Center
Led by Drs. Toren Finkel and Melanie Königshoff, the TriState SenNet TMC combines the expertise of faculty from Pitt, CMU, OSU, and URMC to develop a high-resolution map of the senescent cell population in the human lung and heart, define the physiological drivers of senescence, and provide a rational approach to understand the therapeutic potential of senolytic therapy.